A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04851977 |
|
Recruitment Status :
Completed
First Posted : April 21, 2021
Last Update Posted : April 21, 2021
|
Sponsor:
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.
Information provided by (Responsible Party):
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 7, 2019 |
| Actual Study Completion Date : | August 2, 2019 |